HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2392815Generated: October 27, 2026
ethyl N-(2,3-dichloro-6-nitrobenzyl)glycine hydrochloride → HCID 86753058, compound
https://huagongshe.com/reaction/2392815
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | ethyl N-(2,3-dichloro-6-nitrobenzyl)glycine hydrochloride | HCID 66640009 | — |
| Reactant | Tin (II) chloride-hydrochloride | HCID 86589141 | — |
| Reactant | Anagrelide | HCID 135409400 | — |
| Product | HCID 86753058 | HCID 86753058 | — |
Reaction Steps
The ethyl-N-(2,3-dichloro-6-nitro benzyl) glycine HCl prepared above was used to make Anagrelide by known reactions. Firstly, the ethyl-N-(2,3-dichloro-6-nitro benzyl) glycine HCl is reacted with SnCl2 /HCl to form ethyl-N-(2,3-dichloro-6-amino benzyl) glycine HCl. This material is then reacted with CNBr in an inert, aprotic organic solvent such as toluene or chlorobenzene. The formed ethyl-N-(5,6-dichloro-3,4-dihydro-2(1 H) iminoguinazoline-3-acetate HCl is isolated and then reacted with a base such as triethanolamine (TEA) to form Anagrelide. This synthesis process is shown in U.S. Pat. No. 4,146,718, supra. The Anagrelide product produced had the characteristic pharmaceutical properties of commercially available Anagrelide made using for example, the present prior art synthesis process as described above.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05801245 |
|---|
| Source dataset | uspto-grants-1998_09 |
|---|
| ORD ID | ord-538979e87d39453fa35983b3942b1728 |
|---|
| Source note | uspto-grants-1998_09 |
|---|